Rachna Shroff, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Clovis
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Incyte
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    QED Therapeutics
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Servier
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Taiho
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Zymeworks
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021

Pages

Return to 2022 Summit on Cancer Health Disparities